RxDoctor Payments DataLook up a doctor →

Michael Gottschalk

Pediatric Endocrinology · San Diego, CANPI 1033280888

Payments from drug & device makers

$2,361,317in general payments, 2019–2025

Across 474 payments — averaging $4981.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rhythm Pharmaceuticals, Inc.$867K
  • Eli Lilly$575K
  • Sanofi US Services Inc.$435K
  • Mannkind Corporation$154K
  • Ultragenyx Pharmaceutical Inc.$126K
  • Boehringer Ingelheim$82K
  • plus $122K from 23 others
$8,325in research payments, 2019–2025

Across 2 payments — averaging $4162.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$8K

What the payments were for

  • Consulting fees$6,52039%
  • Speaking & faculty fees$2,02012%
  • Travel & lodging$2,75117%
  • Food & beverage$3,07118%
  • Education$2,18013%
  • Gifts$1191%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,361,317 in reported general payments places this provider in the 95th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California

Other pediatric endocrinology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →